TREM2 and metabolic dysfunction-associated steatohepatitis: In nonalcoholic steatohepatitis (NASH, also known as metabolic dysfunction-related steatohepatitis, MASH), macrophages expressing Trem2 play a key role in promoting its development into hepatocellular carcinoma (HCC).